OCULAR THERAPEUTIX, INC (OCUL) Free cash flow 2016–2025
OCULAR THERAPEUTIX, INC (OCUL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$216.9MFY2025 · since FY2016: -$35.9M → -$216.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$216.9M | -59.5% |
| FY2024 | -$136.0M | -78.1% |
| FY2023 | -$76.3M | -20.5% |
| FY2022 | -$63.3M | +5.1% |
| FY2021 | -$66.7M | -22.7% |
| FY2020 | -$54.4M | +31.8% |
| FY2019 | -$79.8M | -56.1% |
| FY2018 | -$51.1M | +13.0% |
| FY2017 | -$58.7M | -63.5% |
| FY2016 | -$35.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More OCUL financial trends
OCUL RevenueOCUL Net incomeOCUL Net marginOCUL Gross profitOCUL Gross marginOCUL Operating incomeOCUL Operating marginOCUL Operating cash flowOCUL Capital expendituresOCUL Return on equityOCUL Stock buybacksOCUL Dividends paidOCUL Total assetsOCUL Total liabilitiesOCUL Shareholders’ equityOCUL overview →